Regulatory mechanisms modulating the expression of cytochrome P450 1A1 gene by heavy metals

被引:91
作者
Korashy, HM [1 ]
El-Kadi, AOS [1 ]
机构
[1] Univ Alberta, Fac Pharm & Pharmaceut Sci, Dent Pharm Ctr 3126, Edmonton, AB T6G 2N8, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
aryl hydrocarbon receptor; Cyp1a1; heavy metals; transcriptional; posttranscriptional;
D O I
10.1093/toxsci/kfi282
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
We recently demonstrated that heavy metals, Hg2+, Pb2+, and Cu2+ induced Cyp1a1 gene expression, yet the mechanisms involved remain unknown. To explore the molecular mechanisms involved in the modulation of Cyp1a1 by heavy metals, Hepa 1c1c7 cells were treated with the metals in the presence and absence of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a potent Cyp1a1 inducer. Time-dependent effect study showed that all metals significantly induced the basal Cyp1a1 mRNA. This was apparent 3 h after treatment, and levels remained elevated for at least 24 h. At the inducible level, Hg2+ and Pb2+ further increased, while Cu2+ decreased, the TCDD-mediated induction of Cyp1a1 mRNA. The RNA synthesis inhibitor, actinomycin D, completely blocked the Cyp1a1 induction by heavy metals. The protein synthesis inhibitor, cycloheximide, and 26S proteasome inhibitor, carbobenzoxy-L-leucyl-L-leucyl-leucinal (MG-132), superinduced the metal-mediated induction of Cyp1a1 mRNA. In addition, all three metals induced aryl hydrocarbon receptor/xenobiotic-responsive element (AhR/XRE) binding, suggesting an AhR-dependent mechanism. Cyp1a1 mRNA and protein decay experiments showed that the three metals did not significantly affect the half-life of mRNA; however, they significantly decreased the degradation rate of its protein, implying a posttranslational regulation of the Cyp1a1 by the heavy metals. A significant decrease in TCDD-mediated induction of Cyp1a1 activity associated with an increase in HO-1 mRNA and a decrease in cellular heme content was observed after all metals treatment. This suggests that heme degradation plays a role in reducing Cyp1a1 activity. This is the first demonstration that heavy metals can directly induce Cyp1a1 gene expression in an AhR-dependent manner through transcriptional and posttranslational mechanisms.
引用
收藏
页码:39 / 51
页数:13
相关论文
共 39 条
[1]  
[ATSDR Agency for toxic substances and disease registry], 1998, AG TOX SUBST DIS REG
[2]   Mechanisms of arsenite-mediated decreases in benzo[k] fluoranthene-induced human cytochrome P4501A1 levels in HepG2 cells [J].
Bessette, EE ;
Fasco, MJ ;
Pentecost, BT ;
Kaminsky, LS .
DRUG METABOLISM AND DISPOSITION, 2005, 33 (03) :312-320
[3]   Analysis of Ah receptor pathway activation by brominated flame retardants [J].
Brown, DJ ;
Van Overmeire, I ;
Goeyens, L ;
Denison, MS ;
De Vito, MJ ;
Clark, GC .
CHEMOSPHERE, 2004, 55 (11) :1509-1518
[4]  
CHEN T, 1995, INT POLYM PROC, V1, P3
[5]   The steroid hormone dehydroepiandrosterone inhibits CYP1A1 expression in vitro by a post-transcriptional mechanism [J].
Ciolino, HP ;
Yeh, GC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (49) :35186-35190
[6]   INDUCTION, REGULATION AND MESSENGER HALF-LIFE OF CYTOCHROMES-P450 IA1, IA2 AND IIIA6 IN PRIMARY CULTURES OF RABBIT HEPATOCYTES - CYP 1A1, 1A2 AND 3A6 CHROMOSOME LOCATION IN THE RABBIT AND EVIDENCE THAT POSTTRANSCRIPTIONAL CONTROL OF GENE IA2 DOES NOT INVOLVE MESSENGER-RNA STABILIZATION [J].
DAUJAT, M ;
CLAIR, P ;
ASTIER, C ;
FABRE, I ;
PINEAU, T ;
YERLE, M ;
GELLIN, J ;
MAUREL, P .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1991, 200 (02) :501-510
[7]   Benzo[a]pyrene, 3-methylcholanthrene and β-naphthoflavone induce oxidative stress in hepatoma hepa 1c1c7 cells by an AHR-dependent pathway [J].
Elbekai, RH ;
Korashy, HM ;
Wills, K ;
Gharavi, N ;
El-Kadi, AOS .
FREE RADICAL RESEARCH, 2004, 38 (11) :1191-1200
[8]   tert-butylhydroquinone is a novel aryl hydrocarbon receptor ligand [J].
Gharavi, N ;
El-Kadi, AOS .
DRUG METABOLISM AND DISPOSITION, 2005, 33 (03) :365-372
[9]   Cytochrome p450: What have we learned and what are the future issues? [J].
Guengerich, FP .
DRUG METABOLISM REVIEWS, 2004, 36 (02) :159-197
[10]  
Heid SE, 2000, MOL PHARMACOL, V57, P82